Results 231 to 240 of about 418,298 (339)

Psychosocial Nursing Diagnoses of Individuals With Myalgic Encephalomyelitis-Chronic Fatigue Syndrome: A Descriptive Study. [PDF]

open access: yesNurs Open
Oter-Quintana C   +7 more
europepmc   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

open access: yesMed Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin   +8 more
wiley   +1 more source

Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. [PDF]

open access: yesPhysiology (Bethesda)
Syed AM   +4 more
europepmc   +1 more source

Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome

open access: yesJournal of Medical Ethics, 2016
Charlotte Blease   +2 more
semanticscholar   +1 more source

Electrophysiological Evidence for Impaired Central Pain Modulation in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Our study demonstrates electrophysiological evidence of impaired central pain modulation in Parkinson's disease (PD) patients using laser‐evoked potential habituation and quantitative sensory testing. PD patients exhibited reduced habituation to painful stimuli, independent of reported pain or medication.
Dilara Kersebaum   +10 more
wiley   +1 more source

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.

open access: yesAutoimmunity Reviews, 2018
Franziska Sotzny   +6 more
semanticscholar   +1 more source

Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial

open access: yesMovement Disorders, EarlyView.
Abstract Background Neuroinflammation contributes to Parkinson's disease (PD) progression and motor dysfunction. Allogeneic human mesenchymal stem cells (allo‐hMSCs) may reduce neuroinflammation and improve motor symptoms. Objectives To evaluate the efficacy of repeated intravenous doses of 10 × 106/kg allo‐hMSCs in improving motor symptoms in patients
Mya C. Schiess   +15 more
wiley   +1 more source

The efficacy of acupuncture-based chinese medicine in chronic fatigue syndrome: A meta-analysis. [PDF]

open access: yesMedicine (Baltimore)
Feng C   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy